Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Leerink Swann
Manufacturing
BMS nixes BeiGene's Abraxane deal amid legal, production woes
BeiGene is accusing BMS of breaching their contract—and demanding damages—in an arbitration process at the International Chamber of Commerce.
Angus Liu
Oct 14, 2021 10:55am
Gilead could reap remdesivir profits with stockpiling: analyst
Jun 4, 2020 11:26am
Zolgensma delay is bad for Novartis but good for Biogen: analyst
Apr 2, 2020 11:54am
Regeneron needs more innovation à la Dupixent: report
Sep 25, 2019 10:41am
Amgen's overpayment for Otezla could pay off: analysts
Aug 28, 2019 11:00am
Return of Amgen-Alexion deal talk gets cheers from Wall Street
Aug 23, 2019 10:25am
